2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Innovative Radiation and Proton Therapy
Innovative radiation therapies, such as proton therapy, are at the forefront of cancer treatment advancements. Proton therapy uses charged particles, or protons, instead of conventional X-rays to target cancer cells. This precision-targeted approach allows for higher doses of radiation to be delivered directly to the tumor, sparing surrounding healthy tissue from damage. As a result, proton therapy is particularly beneficial for treating tumors located near critical organs, such as brain or spinal tumors. This form of radiation therapy offers fewer side effects and faster recovery times compared to traditional methods, making it a promising option for pediatric patients and those with tumors in delicate areas. The growing availability of proton therapy facilities worldwide further enhances its potential to change the landscape of cancer care.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China